SFX-01 is therapeutic against #MyeloproliferativeDisorders caused by activating mutations in #Shp2

By HJ Cho, J Smith, C Switzer, P. Eaton and colleagues @qmul.bsky.social

🗞️ doi.org/10.1038/s443...

🚨 #JPM21 news starting: @JLimMD’s #ERASCA unveils #SHP2 & #MAPK signaling strategy. Reminds me of @jaybradner’s tweet below.



@PatelOncology @VincentRK @MilkaKostic @DFCI_ChemBio #molecularglues @adamfeuerstein @JohnCendpts @LifeSciVC @HartungIngo